IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.
English
Español
Français
Português
Русский
简体中文
16:40
Duration as a measure of efficacy in botulinum toxins: a double-blind controlled safety trial employing incobotulinum toxin type A
16:50
Duration of Effect in Two Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trials Evaluating Safety & Efficacy of DaxibotulinumtoxinA for Injection Treating Moderate to Severe Glabellar Lines (SAKURA 1 & 2)
17:10
A new microablative method of acousic-inteference microinjury of the tissues as a unique concept of laser technology: the five year practice experience and long-term results: rejuvenation, scars and stretch marks
17:40
Open-label, single-center, single-treatment, safety and effectiveness evaluation of percutaneous radiofrequency